New international dermatology journal Skin launches in Beijing, aims to elevate China’s global academic voice
Business Announcement
Updates every hour. Last Updated: 27-Oct-2026 14:17 ET (27-Oct-2026 18:17 GMT/UTC)
The official launch of Skin, a new fully open-access dermatology journal, was marked by its inaugural editorial board meeting in Beijing on March 14, 2026. Over 160 leading experts gathered to support the journal’s mission to build a world-class academic platform, amplify Chinese research globally, and advance international collaboration in skin health. A tripartite cooperation agreement was signed to accelerate the journal’s development.
Researchers at Weill Cornell Medicine, Cedars-Sinai Medical Center, and Roswell Park Comprehensive Cancer Center have developed genetically engineered CAR T cells that specifically target and kill bladder cancer cells. The study, to be published June 26 in the Journal of Experimental Medicine (JEM), demonstrates that direct delivery of these CAR T cells via a catheter can control bladder tumors in mice, raising hopes that a similar approach may be effective in humans.
This study explores the bidirectional skin–brain axis in 305 Brazilian adults, revealing strong correlations between anxiety, depression, and stress. Women exhibited significantly higher psychological symptom scores than men. Although dermatology-related quality of life showed weak correlations with mental health, nearly half of participants reported skin disorders and over half were at risk for a mental health condition. Probiotic intake showed no significant association with mental health outcomes, likely due to low consumption levels. Stress and depression independently predicted anxiety. The findings underscore the greater psychological burden on women and highlight the need for longitudinal, culturally tailored research on gut–skin–brain interactions.
The gut microbiome plays an important role in inflammatory bowel disease. In the research project MikrobiomProCheck, researchers are investigating how microbiome data can in future be used for diagnostics, disease monitoring and personalised therapies. Bielefeld University is contributing clinical, bioinformatic and data-driven expertise to this collaborative project spanning North Rhine-Westphalia.